MIS, associated with triple rates for pancreatic disease

According to a new study released by researchers at University of California, San Diego School of Medicine proves that MIS (minimally invasive surgery) presents triple rates to pancreatic disease. The work will be published in JAMA Surgery. “For the first time, we show a nationwide tripling of keyhole pancreatic surgery rates for benign and malignant pancreatic disease from 2.4 percent in 1998 to 7.3 percent in 2009”, said Jason Sicklick, MD, assistant professor of surgery, UC San Diego School of Medicine and surgical oncologist at UC San Diego Health System. Sicklick adds that increased surgeon experience leads to less need to perform minimally invasive surgery. In this study, researchers analyzed aspects, such as mortality in hospitals, complication rates, total charges and length of stay. MIS is associated with lower rates of complications, such as lower bleeding-related complications and shorter periods of hospitalization. It is also prove that patients who undergo MIS are the older category.